BlossomHill Therapeutics
BlossomHill Therapeutics is a biotechnology company focused on designing and developing small molecule medicines for cancer and autoimmune diseases. They are building a pipeline of drug candidates aimed at addressing unmet medical needs and improving patient outcomes. Their approach emphasizes novel chemotype design based on a deep understanding of disease science.
Buy Funded Startups lists
Funding Round: Series B
Funding Amount: $100M
Date: 29-Feb-2024
Investors: Colt Ventures, Cormorant Asset Management, OrbiMed, Vivo Capital, Hercules BioVentures Partners LLC, Plaisance Capital Management LLC, H&D Asset Management
Markets: Biotechnology, Oncology, Autoimmune Diseases, Biopharma, Health Care, Pharmaceutical, Therapeutics
HQ: San Diego, California, United States
Founded: 2020
Website: https://bhtherapeutics.com/
LinkedIn: https://www.linkedin.com/company/blossomhill-therapeutics-inc
Twitter: https://twitter.com/bhtherapeutics
Crunchbase: https://www.crunchbase.com/organization/blossomhill-therapeutics
Leave a Comment
Comments
No comments yet.